Top

Archives of Gynecology and Obstetrics

Published in:

01-07-2011 | Gynecologic Oncology

Epidemiology of vulvar and vaginal cancer in Germany

Authors: C. Dittmer, A. Katalinic, C. Mundhenke, M. Thill, D. Fischer

Published in: Archives of Gynecology and Obstetrics | Issue 1/2011

Abstract

Objective

Vulvar and vaginal cancers are rare diseases with an incidence rate that increases with age. At present, epidemiological data are rather scarce. This review article provides an epidemiologic overview of these diseases, focussing on recent German data.

Methods

This review article summarizes the information currently available in order to offer an epidemiologic overview.

Results

The statistic incidence of vulvar carcinoma has been calculated between 2 and 7 cases per 100,000 women, and that of vaginal carcinoma 0.6–1.0 cases per 100,000 women. These incidence rates, especially concerning intraepithelial neoplasm, have increased heavily since the 1970s. The mean age of vulvar cancer affection is 72 years, and 74 years for vaginal carcinoma. In the case of women below the age of 50, cancer tends to be HPV-associated which implies a coincidence of about 20% for cervical and anal cancer. Various pathological mechanisms are the cause for women above the age of 50.

Conclusions

Due to a change in sexual behavior and an increased rate of HPV infection among younger women, increased incidence of both diseases has to be expected. The age-standardized mortality rate of vulvar carcinoma in Europe is stated at 0.7/100,000 women, and that of vaginal carcinoma at 0.4/100.000 women. To what extent the HPV-vaccination affects incidence and mortality rates is continually being observed.

Judson PL, Habermann EB, Baxter NN et al (2006) Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 107(5):1018–1022PubMedCrossRef

Sturgeon SR, Curtis RE, Johnson K et al (1996) Second primary cancers after vulvar and vaginal cancer. AMJ Obstet Gynecol 174(3):929–933CrossRef

Joura EA, Lösch A, Haider-Angeler MG et al (2000) Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 45(8):613–615PubMed

Brinton LA, Nasca PC, Mallin K et al (1990) Case–control study of cancer of the vulva. Obstet Gynecol 75(5):859–866PubMed

Daling JR, Sherman KJ, Hislop TG et al (1992) Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 135(2):180–189PubMed

Sturgeon SR, Brinton LA, Devesa SS et al (1992) In situ, invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 166(5):1482–1485PubMed

Madeleine MM, Daling JR, Carter JJ et al (1997) Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 89(20):1516–1523PubMedCrossRef

http://www.tumorregister-muenchen.de

Santos M, Montagut C, Mellado B et al (2004) Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol 23(3):206–214PubMedCrossRef

10.

Informationszentrum für Standards in der Onkologie—ISTO: Interdisziplinäre Kurzgefasste Leitlinien der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, AWMF-Leitlinienregister 032-032, 2001

11.

Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20(2):207–225PubMedCrossRef

12.

Mandelblatt JS, Kanetsky P, Eggert L et al (1999) Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev 8(1):97–106PubMed

13.

Engel J, Schmidt M, Schubert-Fritschle G (Hrg.) Tumorregister München: Jahresbericht 1999, Zuckschwerdt Verlag Germering

14.

Al-Ghamdi A, Freedman D, Miller D et al (2002) Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol 84(1):94–101PubMedCrossRef

15.

Hording U, Daugaard S, Junge J et al (1996) Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol 15(3):230–234PubMedCrossRef

16.

Bjørge T, Dillner J, Anttila T et al (1997) Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ. 315(7109):646–649PubMed

17.

Santos M, Landolfi S, Olivella A et al (2004) p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 30(11):1347–1356

18.

Sigvardsson S, Hardell L, Przybeck TR et al (1996) Increased cancer risk among Swedish female alcoholics. Epidemiology 7(2):140–143PubMedCrossRef

19.

Daling JR, Chu J, Weiss NS et al (1984) The association of condylomata acuminata and squamous carcinoma of the vulva. Br J Cancer 50(4):533–535PubMedCrossRef

20.

Koyamatsu Y, Yokoyama M, Nakao Y et al (2003) A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Gynecol Oncol 90(3):547–551PubMedCrossRef

21.

Rolfe KJ et al (2003) TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer 89(12):2249–2253PubMedCrossRef

22.

Mardh PA (1991) The vaginal ecosystem. Am J Obstet Gynecol 165:1163–1168PubMed

23.

Ries LAG, Kossary CL, Hankey BF et al (1998) SEER Cancer statistics Review, 1973–1995. National Cancer Institute, Bethesda

24.

http://www.destatis.de

25.

Beller U, Sideri M, Maisonneuve P et al (2001) Carcinoma of the vagina. J Epidemiol Biostat 6(1):141–152PubMed

26.

Fu YS (2002) Pathology of the uterine cervix, vagina, and vulva, 2nd edn. Saunders, Philadelphia, p 531

27.

Creasman WT, Phillips JL, Menck HR (1998) The National cancer data base report on cancer of the vagina. Cancer 83:1033PubMedCrossRef

28.

Herbst AL, Ulfelder H, Poskanzer DC et al (1991) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol 181(6):1574–1575CrossRef

29.

Carter JJ et al (2001) Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61(5):1934–1940PubMed

30.

Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84(2):263–270PubMedCrossRef

31.

Hampl M et al (2006) Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol 108(6):1361–1368PubMedCrossRef

32.

Madsen BS et al (2008) Risk factors for invasive squamous cell carcinoma of the vulva and vagina–population-based case-control study in Denmark. Int J Cancer 122(12):2827–2834PubMedCrossRef

33.

Wassberg C et al (1999) Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 80(4):511–515PubMedCrossRef

34.

Benedet JL, Murphy KJ, Fairey RN et al (1983) Primary invasive carcinoma of the vagina. Obstet Gynecol 62(6):715–719PubMed

35.

Eddy GL, Marks RD, Miller MC et al (1991) Primary invasive vaginal carcinoma. Am J Obstet Gynecol 165(2):292–296PubMed

36.

Frisch M, Olsen JH, Melbye M (1994) Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol 140(1):12–19PubMed

37.

Hussain SK et al (2008) Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish family-cancer database. Int J Cancer 122(8):1873–1878PubMedCrossRef

38.

Parazzini F et al (1995) Selected food intake and risk of vulvar cancer. Cancer 76(11):2291–2296PubMedCrossRef

39.

Basta A, Adamek K, Pitynski K (1999) Intraepithelial neoplasia and early stage vulvar cancer. Epidemiological, clinical and virological observations. Eur J Gynaecol Oncol 20(2):111–114PubMed

40.

Trimble CL et al (1996) Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 87(1):59–64PubMedCrossRef

41.

Baumann KH, Müller O, Naujok HB et al (2010) Small-area analysis of incidence and localisation of vulvar cancer. J Oncol 2010:512032PubMed

Title: Epidemiology of vulvar and vaginal cancer in Germany
Authors: C. Dittmer
A. Katalinic
C. Mundhenke
M. Thill
D. Fischer
Publication date: 01-07-2011
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 1/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-011-1850-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Epidemiology of vulvar and vaginal cancer in Germany

Abstract

Objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2011

Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women

Three-dimensional power Doppler study of changes in uterine vascularity after absorbable cervical tourniquet during open myomectomy

Human papilloma virus persistence and neopterin, folate and homocysteine levels in cervical dysplasias

An evolutionary insight into mutation of ATPase6 gene in primary ovarian insufficiency

Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer

The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma